Metabolic Engineering Strategy for Synthetizing Trans-4-Hydroxy-L

Total Page:16

File Type:pdf, Size:1020Kb

Metabolic Engineering Strategy for Synthetizing Trans-4-Hydroxy-L Zhang et al. Microb Cell Fact (2021) 20:87 https://doi.org/10.1186/s12934-021-01579-2 Microbial Cell Factories REVIEW Open Access Metabolic engineering strategy for synthetizing trans-4-hydroxy-L-proline in microorganisms Zhenyu Zhang1†, Pengfu Liu1†, Weike Su1,2, Huawei Zhang2, Wenqian Xu1 and Xiaohe Chu1* Abstract Trans-4-hydroxy-L-proline is an important amino acid that is widely used in medicinal and industrial applications, par- ticularly as a valuable chiral building block for the organic synthesis of pharmaceuticals. Traditionally, trans-4-hydroxy- L-proline is produced by the acidic hydrolysis of collagen, but this process has serious drawbacks, such as low produc- tivity, a complex process and heavy environmental pollution. Presently, trans-4-hydroxy-L-proline is mainly produced via fermentative production by microorganisms. Some recently published advances in metabolic engineering have been used to efectively construct microbial cell factories that have improved the trans-4-hydroxy-L-proline biosyn- thetic pathway. To probe the potential of microorganisms for trans-4-hydroxy-L-proline production, new strategies and tools must be proposed. In this review, we provide a comprehensive understanding of trans-4-hydroxy-L-proline, including its biosynthetic pathway, proline hydroxylases and production by metabolic engineering, with a focus on improving its production. Keywords: Trans-4-hydroxy-L-proline, Biosynthetic pathway, Proline hydroxylases, Metabolic engineering Background t4Hyp being present only in the Y position [1]. T4Hyp Hydroxyprolines are a series of hydroxylated derivatives was previously considered to have little nutritional sig- of proline comprising six isomers—trans-4-hydroxy- nifcance but is now thought to be a major precursor for l-proline (t4Hyp), trans-3-hydroxy-l-proline (t3Hyp), the synthesis of glycine, pyruvate, and glucose. Some evi- cis-4-hydroxy-l-proline (c4Hyp), cis-3-hydroxy-l-pro- dence supports the ability of t4Hyp to scavenge oxidants, line (c3Hyp), trans-5-hydroxy-l-proline (t5Hyp), and regulate the state of cellular reduction and stimulate the cis-5-hydroxy-l-proline (c5Hyp) (Fig. 1). Furthermore, expression of anti-oxidative enzymes in the cell [2, 3]. t4Hyp is a major amino acid in collagen proteins, which T4Hyp is required for normal secretion after protein contain two α1 and one α2 polypeptide chain, to allow synthesis and contributes to the integrity of the triple- the sharp twisting of the collagen helix and are the major helical conformation [4]. In animals, t4Hyp is produced extracellular components of connective tissues, such as by the posttranslational hydroxylation of proline resi- skin, tendon, cartilage, blood vessels, and bone. Te heli- dues in proteins [5, 6]. T4Hyp is a nonessential α-amino cal region of collagen comprises Gly-X-Y repeats, with acid and is present in several secondary metabolites (e.g., echinocandins and etamycin) [7]. Additionally, t4Hyp has been widely used in the medicine, biochemistry, food, *Correspondence: [email protected] †Zhenyu Zhang and Pengfu Liu contributed equally to this work and cosmetic industries and is usually used as a valuable 1 Collaborative Innovation Center of Yangtze River Delta Region Green building block for the synthesis of many pharmaceu- Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ticals [8]. T4Hyp can be used to synthesize many com- Zhejiang, People’s Republic of China Full list of author information is available at the end of the article pounds, such as glutamic acid analogs, kainoid analogs © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Zhang et al. Microb Cell Fact (2021) 20:87 Page 2 of 15 (a class of nonproteinogenic amino acids with a broad Artifcial biosynthetic pathway spectrum of biological activities), arginine analogs, and of trans‑4‑hydroxy‑L‑proline in Escherichia coli pipecolic acid and its derivatives (which play important and Corynebacterium glutamicum biological roles as components of peptides, proteins, and Te main types of microorganisms currently used to intermediates for the synthesis of conformationally con- produce t4Hyp are Escherichia coli and Corynebacte- strained molecular scafolds) through diastereoselective rium glutamicum (Fig. 3) [19]. In particular, because synthesis, N,Nʹ-dioxides, carbapenem antibiotics (imipe- of a lack of proline hydroxylases, proline hydroxylase nem, meropenem, panipenem), angiotensin-converting is introduced into E. coli and C. glutamicum and exog- enzyme inhibitors, N-aryl pyrroles (important organic enously expressed to form a complete t4Hyp synthe- compounds for medicinal and material sciences), oxace- sis pathway. Glucose as a substrate undergoes a series prol (an atypical inhibitor of infammation used for the of biochemical reactions to produce α-ketoglutarate treatment of conditions afecting the connective tissues, (α-KG). Subsequently, α-KG is catalyzed to form glu- such as osteoarthritis), oligomers, and macrocycles (usu- tamate via glutamate synthase. Te synthesis pathway ally used as valuable sources of bioactive molecules that from glutamate to proline requires three enzymatic have properties such as good solubility and metabolite reactions (Fig. 4) [20]. First, glutamate is catalyzed stability for drug discovery) (Fig. 2) [9–18]. to γ-glutamyl phosphate by γ-glutamyl kinase. Tis enzyme is the rate-limiting enzyme of proline synthe- sis and can be inhibited by proline feedback [21]. Typi- cally, the enzyme is a homotetramer of a 367-amino acid polypeptide comprising an N-terminal 257-resi- due amino acid kinase (AAK) domain along with a 110-residue PUA (named for pseudo uridine synthases Fig. 1 Structures of the hydroxyproline isomers. a trans-4-hydroxy-L-proline. b trans-3-hydroxy-L-proline. c cis-4-hydroxy-L-proline. d cis-3-hydroxy-L-proline, and e 5-hydroxy-L-proline Zhang et al. Microb Cell Fact (2021) 20:87 Page 3 of 15 Fig. 2 Compounds for which the parent structure is hydroxyproline and archaeosine-specifc transglycosylases) domain dehydrogenase occur in a complex, and γ-glutamyl [22]. Glutamate-γ-semialdehyde dehydrogenase cat- kinase activity is undetectable in the absence of alyzes the second reaction of proline biosynthesis glutamate-γ-semialdehyde dehydrogenase [24, 25]. and activates γ-glutamyl phosphate to glutamate-γ- Glutamate-γ-semialdehyde then cyclizes spontaneously semialdehyde. Te enzyme is not susceptible to either to form pyrroline-5-carboxylate (an internal Schif end-product prohibition or inhibition by proline [23]. base). In the third reaction of the proline biosynthetic γ-Glutamyl kinase and glutamate-γ-semialdehyde Zhang et al. Microb Cell Fact (2021) 20:87 Page 4 of 15 Fig. 3 Biosynthetic pathway of hydroxyproline pathway, pyrroline-5-carboxylate is reduced to proline of pyrroline-5-carboxylate reductase, and NADPH by pyrroline-5-carboxylate reductase. Pyrroline-5-car- demonstrates higher activity than NADH [26]. boxylate reductase mediates the pyridine nucleotide- linked reduction of pyrroline-5-carboxylate to proline Catabolism of proline but not the reverse reaction, even at high substrate Proline can be catabolized to glutamate through two concentrations. NADPH and NADH are both cofactors enzymatic steps (Fig. 5). Te E. coli PutA protein com- prises 1320 amino acid residues, and its dimer has a Zhang et al. Microb Cell Fact (2021) 20:87 Page 5 of 15 Fig. 4 Synthesis pathway from glutamate to proline Fig. 5 Proline is catabolized to glutamate via two enzymatic steps. PRODH proline dehydrogenase, P5CDH pyrroline-5-carboxylate dehydrogenase molecular mass of 293 kDa [27]. PutA is a multifunc- to an acceptor in the electron transport chain to com- tional favor-protein that is both a membrane-associated plete the catalytic cycle. In the second step of reaction, proline catabolic enzyme and a transcriptional repressor non-enzymatic hydrolysis of pyrroline-5-carboxylate of a pair of genes encoding proline utilization proteins generates glutamic semi-aldehyde; subsequently, glu- [28]. Te frst enzymatic step is that proline is catalyzed tamic semi-aldehyde is oxidized to glutamate through to generate pyrroline-5-carboxylate by PutA. Te elec- the transfer of two electrons to reduce NAD + to NADH trons from reduced FAD are subsequently transferred [29]. Tere is some evidence that PutA has DNA-binding Zhang et al. Microb Cell Fact (2021) 20:87 Page 6 of 15 activity and serves as a transcriptional repressor of the Dactylosporangium sp.RH1) [42], l-proline cis-3-hydrox- putP and putA genes (proline utilization regulon) in E. ylase (cis-P3H, from the Streptomyces sp. strain TH1) coli [27]. In E. coli, the regulation of put genes relies on [43], and l-proline cis-4-hydroxylase (cis-P4H, from Mes- the concentration of proline and intracellular location orhizobium loti and Sinorhizobium meliloti) [44], and of the PutA protein [30]. In the presence of proline, the convert l-proline to generate trans-3-hydroxy-l-proline, localization of PutA changes from the cytoplasm to the trans-4-hydroxy-l-proline, cis-3-hydroxy-l-proline, membrane. Te transcription of put genes is then acti- and cis-3-hydroxy-l-proline, respectively.
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0089535 A1 Yamashiro Et Al
    US 2013 0089535A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0089535 A1 Yamashiro et al. (43) Pub. Date: Apr. 11, 2013 (54) AGENT FOR REDUCING ACETALDEHYDE Publication Classification NORAL CAVITY (51) Int. Cl. (75) Inventors: Kan Yamashiro, Kakamigahara-shi (JP); A68/66 (2006.01) Takahumi Koyama, Kakamigahara-shi A638/51 (2006.01) (JP) A61O 11/00 (2006.01) A638/44 (2006.01) Assignee: AMANOENZYME INC., Nagoya-shi (52) U.S. Cl. (73) CPC. A61K 8/66 (2013.01); A61K 38/44 (2013.01); (JP) A61 K38/51 (2013.01); A61O II/00 (2013.01) (21) Appl. No.: 13/703,451 USPC .......... 424/94.4; 424/94.5; 435/191: 435/232 (22) PCT Fled: Jun. 7, 2011 (57) ABSTRACT Disclosed herein is a novel enzymatic agent effective in (86) PCT NO.: PCT/UP2011/062991 reducing acetaldehyde in the oral cavity. It has been found S371 (c)(1), that an aldehyde dehydrogenase derived from a microorgan (2), (4) Date: Dec. 11, 2012 ism belonging to the genus Saccharomyces and a threonine aldolase derived from Escherichia coli are effective in reduc (30) Foreign Application Priority Data ing low concentrations of acetaldehyde. Therefore, an agent for reducing acetaldehyde in the oral cavity is provided, Jun. 19, 2010 (JP) ................................. 2010-140O26 which contains these enzymes as active ingredients. Patent Application Publication Apr. 11, 2013 Sheet 1 of 2 US 2013/0089535 A1 FIG 1) 10.5 1 0 9.9.5 8. 5 CONTROL TA AD (BSA) ENZYME Patent Application Publication Apr. 11, 2013 Sheet 2 of 2 US 2013/0089535 A1 FIG 2) 110 the CONTROL (BSA) 100 354.
    [Show full text]
  • Organic & Biomolecular Chemistry
    Organic & Biomolecular Chemistry Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/obc Page 1 of 14 Organic & Biomolecular Chemistry Enantioselective imine reduction catalyzed by imine reductases and artificial metalloenzymes Daniela Gamenara a* , Pablo Domínguez de María b,c* Manuscript a: Organic Chemistry Department. Universidad de la República (UdelaR). Gral. Flores 2124. 11800 Montevideo, Uruguay. b: Institut für Technische und Makromolekulare Chemie (ITMC), Accepted RWTH Aachen University. Worringerweg 1. 52074 Aachen, Germany. c: Present address: Sustainable Momentum . Ap. Correos 3517. 35004, Las Palmas de Gran Canaria; Canary Islands; Spain. Chemistry Biomolecular & * Corresponding Authors: Dr. Daniela Gamenara. Tel.: +598 29247881; Fax: +598 29241906; E-mail: [email protected] ; Dr.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Letters to Nature
    letters to nature Received 7 July; accepted 21 September 1998. 26. Tronrud, D. E. Conjugate-direction minimization: an improved method for the re®nement of macromolecules. Acta Crystallogr. A 48, 912±916 (1992). 1. Dalbey, R. E., Lively, M. O., Bron, S. & van Dijl, J. M. The chemistry and enzymology of the type 1 27. Wolfe, P. B., Wickner, W. & Goodman, J. M. Sequence of the leader peptidase gene of Escherichia coli signal peptidases. Protein Sci. 6, 1129±1138 (1997). and the orientation of leader peptidase in the bacterial envelope. J. Biol. Chem. 258, 12073±12080 2. Kuo, D. W. et al. Escherichia coli leader peptidase: production of an active form lacking a requirement (1983). for detergent and development of peptide substrates. Arch. Biochem. Biophys. 303, 274±280 (1993). 28. Kraulis, P.G. Molscript: a program to produce both detailed and schematic plots of protein structures. 3. Tschantz, W. R. et al. Characterization of a soluble, catalytically active form of Escherichia coli leader J. Appl. Crystallogr. 24, 946±950 (1991). peptidase: requirement of detergent or phospholipid for optimal activity. Biochemistry 34, 3935±3941 29. Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and (1995). the thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281±296 (1991). 4. Allsop, A. E. et al.inAnti-Infectives, Recent Advances in Chemistry and Structure-Activity Relationships 30. Meritt, E. A. & Bacon, D. J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505± (eds Bently, P. H. & O'Hanlon, P. J.) 61±72 (R. Soc. Chem., Cambridge, 1997).
    [Show full text]
  • Supplementary Informations SI2. Supplementary Table 1
    Supplementary Informations SI2. Supplementary Table 1. M9, soil, and rhizosphere media composition. LB in Compound Name Exchange Reaction LB in soil LBin M9 rhizosphere H2O EX_cpd00001_e0 -15 -15 -10 O2 EX_cpd00007_e0 -15 -15 -10 Phosphate EX_cpd00009_e0 -15 -15 -10 CO2 EX_cpd00011_e0 -15 -15 0 Ammonia EX_cpd00013_e0 -7.5 -7.5 -10 L-glutamate EX_cpd00023_e0 0 -0.0283302 0 D-glucose EX_cpd00027_e0 -0.61972444 -0.04098397 0 Mn2 EX_cpd00030_e0 -15 -15 -10 Glycine EX_cpd00033_e0 -0.0068175 -0.00693094 0 Zn2 EX_cpd00034_e0 -15 -15 -10 L-alanine EX_cpd00035_e0 -0.02780553 -0.00823049 0 Succinate EX_cpd00036_e0 -0.0056245 -0.12240603 0 L-lysine EX_cpd00039_e0 0 -10 0 L-aspartate EX_cpd00041_e0 0 -0.03205557 0 Sulfate EX_cpd00048_e0 -15 -15 -10 L-arginine EX_cpd00051_e0 -0.0068175 -0.00948672 0 L-serine EX_cpd00054_e0 0 -0.01004986 0 Cu2+ EX_cpd00058_e0 -15 -15 -10 Ca2+ EX_cpd00063_e0 -15 -100 -10 L-ornithine EX_cpd00064_e0 -0.0068175 -0.00831712 0 H+ EX_cpd00067_e0 -15 -15 -10 L-tyrosine EX_cpd00069_e0 -0.0068175 -0.00233919 0 Sucrose EX_cpd00076_e0 0 -0.02049199 0 L-cysteine EX_cpd00084_e0 -0.0068175 0 0 Cl- EX_cpd00099_e0 -15 -15 -10 Glycerol EX_cpd00100_e0 0 0 -10 Biotin EX_cpd00104_e0 -15 -15 0 D-ribose EX_cpd00105_e0 -0.01862144 0 0 L-leucine EX_cpd00107_e0 -0.03596182 -0.00303228 0 D-galactose EX_cpd00108_e0 -0.25290619 -0.18317325 0 L-histidine EX_cpd00119_e0 -0.0068175 -0.00506825 0 L-proline EX_cpd00129_e0 -0.01102953 0 0 L-malate EX_cpd00130_e0 -0.03649016 -0.79413596 0 D-mannose EX_cpd00138_e0 -0.2540567 -0.05436649 0 Co2 EX_cpd00149_e0
    [Show full text]
  • OXPHOS Remodeling in High-Grade Prostate Cancer Involves Mtdna Mutations and Increased Succinate Oxidation
    ARTICLE https://doi.org/10.1038/s41467-020-15237-5 OPEN OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation Bernd Schöpf 1, Hansi Weissensteiner 1, Georg Schäfer2, Federica Fazzini1, Pornpimol Charoentong3, Andreas Naschberger1, Bernhard Rupp1, Liane Fendt1, Valesca Bukur4, Irina Giese4, Patrick Sorn4, Ana Carolina Sant’Anna-Silva 5, Javier Iglesias-Gonzalez6, Ugur Sahin4, Florian Kronenberg 1, ✉ Erich Gnaiger 5,6 & Helmut Klocker 7 1234567890():,; Rewiring of energy metabolism and adaptation of mitochondria are considered to impact on prostate cancer development and progression. Here, we report on mitochondrial respiration, DNA mutations and gene expression in paired benign/malignant human prostate tissue samples. Results reveal reduced respiratory capacities with NADH-pathway substrates glu- tamate and malate in malignant tissue and a significant metabolic shift towards higher succinate oxidation, particularly in high-grade tumors. The load of potentially deleterious mitochondrial-DNA mutations is higher in tumors and associated with unfavorable risk factors. High levels of potentially deleterious mutations in mitochondrial Complex I-encoding genes are associated with a 70% reduction in NADH-pathway capacity and compensation by increased succinate-pathway capacity. Structural analyses of these mutations reveal amino acid alterations leading to potentially deleterious effects on Complex I, supporting a causal relationship. A metagene signature extracted from the transcriptome of tumor samples exhibiting a severe mitochondrial phenotype enables identification of tumors with shorter survival times. 1 Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University Innsbruck, Schöpfstraße 41, A-6020 Innsbruck, Austria. 2 Institute of Pathology, Neuropathology and Molecular Pathology, Medical University Innsbruck, Müllerstraße 44, A-6020 Innsbruck, Austria.
    [Show full text]
  • Four Distinct Types of E.C. 1.2.1.30 Enzymes Can Catalyze the Reduction
    Journal of Biotechnology 257 (2017) 222–232 Contents lists available at ScienceDirect Journal of Biotechnology j ournal homepage: www.elsevier.com/locate/jbiotec Four distinct types of E.C. 1.2.1.30 enzymes can catalyze the reduction of carboxylic acids to aldehydes a,b b c d Holly Stolterfoht , Daniel Schwendenwein , Christoph W. Sensen , Florian Rudroff , a,b,∗ Margit Winkler a Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, 8010 Graz, Austria b acib GmbH, Petersgasse 14, 8010 Graz, Austria c Institute of Computational Biotechnology, Graz University of Technology, Petersgasse 14, 8010 Graz, Austria d Institute of Applied Synthetic Chemistry, TU Wien, Getreidemarkt 9/OC-163, 1060 Vienna, Austria a r t i c l e i n f o a b s t r a c t Article history: Increasing demand for chemicals from renewable resources calls for the development of new biotech- Received 13 December 2016 nological methods for the reduction of oxidized bio-based compounds. Enzymatic carboxylate reduction Received in revised form 8 February 2017 is highly selective, both in terms of chemo- and product selectivity, but not many carboxylate reductase Accepted 14 February 2017 enzymes (CARs) have been identified on the sequence level to date. Thus far, their phylogeny is unexplored Available online 20 February 2017 and very little is known about their structure-function-relationship. CARs minimally contain an adenyla- tion domain, a phosphopantetheinylation domain and a reductase domain. We have recently identified Keywords: new enzymes of fungal origin, using similarity searches against genomic sequences from organisms in Carboxylate reductase Biocatalysis which aldehydes were detected upon incubation with carboxylic acids.
    [Show full text]
  • Natural Isotope Abundances of Carbon and Nitrogen in Tissue
    nutrients Article Natural Isotope Abundances of Carbon and Nitrogen in Tissue Proteins and Amino Acids as Biomarkers of the Decreased Carbohydrate Oxidation and Increased Amino Acid Oxidation Induced by Caloric Restriction under a Maintained Protein Intake in Obese Rats , Jean-François Huneau * y , Olivier L. Mantha y, Dominique Hermier ,Véronique Mathé, Guillaume Galmiche, François Mariotti and Hélène Fouillet UMR PNCA, AgroParisTech, INRA, Université Paris-Saclay, 75005 Paris, France; [email protected] (O.L.M.); [email protected] (D.H.); [email protected] (V.M.); [email protected] (G.G.); [email protected] (F.M.); [email protected] (H.F.) * Correspondence: [email protected] Both authors contributed equally to this study. y Received: 25 March 2019; Accepted: 14 May 2019; Published: 16 May 2019 Abstract: A growing body of evidence supports a role for tissue-to-diet 15N and 13C discrimination factors (D15N and D13C), as biomarkers of metabolic adaptations to nutritional stress, but the underlying mechanisms remain poorly understood. In obese rats fed ad libitum or subjected to gradual caloric restriction (CR), under a maintained protein intake, we measured D15N and D13C levels in tissue proteins and their constitutive amino acids (AA) and the expression of enzymes involved in the AA metabolism. CR was found to lower protein mass in the intestine, liver, heart and, to a lesser extent, some skeletal muscles. This was accompanied by D15N increases in urine and the protein of the liver and plasma, but D15N decreases in the proteins of the heart and the skeletal muscles, alongside D13C decreases in all tissue proteins.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]
  • Plastid-Localized Amino Acid Biosynthetic Pathways of Plantae Are Predominantly Composed of Non-Cyanobacterial Enzymes
    Plastid-localized amino acid biosynthetic pathways of Plantae are predominantly SUBJECT AREAS: MOLECULAR EVOLUTION composed of non-cyanobacterial PHYLOGENETICS PLANT EVOLUTION enzymes PHYLOGENY Adrian Reyes-Prieto1* & Ahmed Moustafa2* Received 1 26 September 2012 Canadian Institute for Advanced Research and Department of Biology, University of New Brunswick, Fredericton, Canada, 2Department of Biology and Biotechnology Graduate Program, American University in Cairo, Egypt. Accepted 27 November 2012 Studies of photosynthetic eukaryotes have revealed that the evolution of plastids from cyanobacteria Published involved the recruitment of non-cyanobacterial proteins. Our phylogenetic survey of .100 Arabidopsis 11 December 2012 nuclear-encoded plastid enzymes involved in amino acid biosynthesis identified only 21 unambiguous cyanobacterial-derived proteins. Some of the several non-cyanobacterial plastid enzymes have a shared phylogenetic origin in the three Plantae lineages. We hypothesize that during the evolution of plastids some enzymes encoded in the host nuclear genome were mistargeted into the plastid. Then, the activity of those Correspondence and foreign enzymes was sustained by both the plastid metabolites and interactions with the native requests for materials cyanobacterial enzymes. Some of the novel enzymatic activities were favored by selective compartmentation should be addressed to of additional complementary enzymes. The mosaic phylogenetic composition of the plastid amino acid A.R.-P. ([email protected]) biosynthetic pathways and the reduced number of plastid-encoded proteins of non-cyanobacterial origin suggest that enzyme recruitment underlies the recompartmentation of metabolic routes during the evolution of plastids. * Equal contribution made by these authors. rimary plastids of plants and algae are the evolutionary outcome of an endosymbiotic association between eukaryotes and cyanobacteria1.
    [Show full text]
  • Genome-Scale Metabolic Network Analysis and Drug Targeting of Multi-Drug Resistant Pathogen Acinetobacter Baumannii AYE
    Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is © The Royal Society of Chemistry 2017 Electronic Supplementary Information (ESI) for Molecular BioSystems Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE Hyun Uk Kim, Tae Yong Kim and Sang Yup Lee* E-mail: [email protected] Supplementary Table 1. Metabolic reactions of AbyMBEL891 with information on their genes and enzymes. Supplementary Table 2. Metabolites participating in reactions of AbyMBEL891. Supplementary Table 3. Biomass composition of Acinetobacter baumannii. Supplementary Table 4. List of 246 essential reactions predicted under minimal medium with succinate as a sole carbon source. Supplementary Table 5. List of 681 reactions considered for comparison of their essentiality in AbyMBEL891 with those from Acinetobacter baylyi ADP1. Supplementary Table 6. List of 162 essential reactions predicted under arbitrary complex medium. Supplementary Table 7. List of 211 essential metabolites predicted under arbitrary complex medium. AbyMBEL891.sbml Genome-scale metabolic model of Acinetobacter baumannii AYE, AbyMBEL891, is available as a separate file in the format of Systems Biology Markup Language (SBML) version 2. Supplementary Table 1. Metabolic reactions of AbyMBEL891 with information on their genes and enzymes. Highlighed (yellow) reactions indicate that they are not assigned with genes. No. Metabolism EC Number ORF Reaction Enzyme R001 Glycolysis/ Gluconeogenesis 5.1.3.3 ABAYE2829
    [Show full text]
  • Gene Expression and Activity of Enzymes in the Arginine Biosynthetic Pathway in Porcine Fetal Small Intestine
    0031-3998/03/5302-0274 PEDIATRIC RESEARCH Vol. 53, No. 2, 2003 Copyright © 2003 International Pediatric Research Foundation, Inc. Printed in U.S.A. Gene Expression and Activity of Enzymes in the Arginine Biosynthetic Pathway in Porcine Fetal Small Intestine CHRISTOPHER M. DEKANEY, GUOYAO WU, AND LAURIE A. JAEGER Department of Veterinary Anatomy and Public Health [C.M.D., G.W., L.A.J.], Department of Animal Science [G.W., L.A.J.], and Center for Animal Biotechnology and Genomics [L.A.J.], Institute of Biosciences and Technology ABSTRACT We recently reported the presence of ornithine aminotrans- OAT suggests that the fetal porcine small intestine is capable of ferase (OAT) enzymatic activity and mRNA expression in the synthesizing citrulline from P5C. In addition, the presence of intestine of fetal pigs from 30 to 110 d of gestation. Here we P5CR suggests that the fetal porcine small intestine is able to describe the activities and mRNA expression patterns of other synthesize proline from ornithine via OAT. This ability of the key enzymes in the arginine biosynthetic pathway, specifically fetal small intestine to synthesize amino acids may be important carbamoyl phosphate synthase I (CPS-I), ornithine carbamoyl for development and metabolic activity of the intestine during transferase (OCT), and pyrroline-5-carboxylate reductase somatic growth of the fetus. (Pediatr Res 53: 274–280, 2003) (P5CR), in the fetal porcine small intestine from 30 to 110 d of gestation. The activities of all three enzymes increased from d 30 Abbreviations to d 110 of gestation, and in situ hybridization demonstrates that OAT, ornithine aminotransferase 1) CPS-I and OCT genes are expressed in distinct patterns and CPS-I, carbamoyl phosphate synthase I are confined to the mucosal epithelium and 2) P5CR mRNA is OCT, ornithine carbamoyl transferase present in mucosal epithelium and lamina propria of the fetal P5CR, pyrroline-5-carboxylate reductase porcine small intestine from d 30 to d 110 of gestation.
    [Show full text]